hK2及其相关指标在前列腺癌诊断中的应用
被引量：3
摘要
血清hk2、hk2 /f PSA以及hk/2 (f PSA/t PSA)是一类新的前列腺癌的筛选诊断指标 ,与PSA以及f PSA/t PSA比较 ,对前列腺癌的诊断可能更准确、更具有特异性 ,能使更多的非前列腺癌患者免受前列腺活检之苦。本文就hk2的生物学性质、常用的检测方法以及hk2及其相关指标在前列腺癌诊断中的应用作一综述。
出处
《国外医学（临床生物化学与检验学分册）》
CAS
2001年第4期195-196,共2页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
参考文献10
-
1Magklara A,Scorilas A,Catalona WJ,et al.The combination of human glandular kallikrein and free prostate-specific antigen(PSA)enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA[].Clinical Chemistry.1999
-
2Becker C,Piironen T,Petterson K,et al.Clinical value of human glandular kallikrein and free and total prostate specific antigen in serum from a population of men with prostate-specitic antigen level 3. 0ng/ml or greater[].Urology.2000
-
3Nam RK,Diancondis EP,Toi A,et al.Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen[].Journal of Clinical Oncology.2000
-
4Klee GG,Goodmanson MK,Jacobsen S,et al.Highly sensitive automated chemiluminometric assay for free human glandular kallikrein-2[].Clinical Chemistry.1999
-
5Magklara A,Scorias A,Lopen-Otin C,et al.human glandular kallikrein in breast milk, Aniniotic fluid, and breast cyst fluid[].Clinical Chemistry.1999
-
6Kwiatkowski MK,Becker F,Piiromen T,et al.Inprostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign prostatic hyperplasia within the diagnostic "gray zone "of total PSA 4-10ng/ml[].Urology.1998
-
7Frenette G,Deperthes D,Tremblay RR,et al.Purification of enzymatically active kallikrein hk2 from human seminal plasma[].Biochimica et Biophysica Acta.1997
-
8Finlay JA,Evans CL,Day JR,et al.Development of monoclonal antibodies specific for human glandular kallikrein(hk2): development of a dual antibody immunoassay for hk2 with negligible prostate-specific antigen cross-reactivity[].Urology.1998
-
9Becker F,Kwiatkowski MK,Piironen T,et al.Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen[].Urology.2000
-
10Black MH,Mageliki A,Obiezu C,et al.Development of an ultrasensitive immunoassy for human glandular kallikrein with on cross-reactivity from prostate-specific antigen[].Clinical Chemistry.1999
同被引文献19
-
1McComack RT, Rittenhouse HG, Finlay, et al. MolecularFormsof- ProstateSpecificAntigen and Human KallikreinGeneFamily; A New Era. Urology, 1995,45 ( 5 ) : 729 -744.
-
2Matsuyama H, Baba Y, Yamakawa G. et al. Diagnostic value of prostate-specific antigen-related parameters in discriminating pros- tate cancer. Int J Urol, 2000,7( 11 ) :409-414.
-
3Riegman PH, Vlietstra RJ, Suurmeijer L, et al. Characterization of the human kallikrein locus. Genomics, 1992, 14(1):6-11.
-
4Diamandis EP, Yousef GM, Clements J, et al. New nomenclature for the human tissue kallikrein gene family. Clin Chem, 2000, 46(11): 1855-1858.
-
5Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem, 2002, 48(8): 1198-1205.
-
6Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clin Biochem, 2003, 36(6): 443-452.
-
7Clements J, Hooper J, Dong Y, et al. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Biol Chem, 2001, 382(1): 5-14.
-
8Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev, 2001, 22(2): 184-204.
-
9Yousef GM, Diamandis EP. Expanded human tissue kallikrein family--a novel panel of cancer biomarkers. Tumour Biol, 2002, 23(3): 185-192.
-
10Nakamura T, Scorilas A, Stephan C, et al. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. Cancer Res, 2003, 63(19): 6543-6546.
-
1于勇,李道源,陆浩源,蒙清贵,白先忠.hK2、Ki-67在前列腺癌组织中的表达及其临床意义[J].中国癌症防治杂志,2012,4(2):190-193. 被引量：5
-
2覃沃浩,熊海新,梁其仲,刘杰中.T-PSA和f-PSA在前列腺癌诊断中的意义[J].中国民族民间医药,2013,22(12):89-90. 被引量：1
-
3肖慧杰,申震,张凯,姜洋,刘铜军.HIF-1α在结直肠癌中的表达及临床意义[J].中国老年学杂志,2013,33(4):794-795. 被引量：2
-
4李善昌,吴骞,丁元圣,孙宇,闫磊.AKT和HK2在口腔鳞状细胞癌中的表达[J].黑龙江医药科学,2016,39(1):19-21. 被引量：2
-
5祝宇,吴瑜璇,刘定益,周文龙,芮文斌,王浩飞,孙福康.磁共振成像在前列腺癌诊断中的作用[J].临床泌尿外科杂志,2002,17(10):533-534. 被引量：3
-
6刘玉琴,高进.转移潜能不同的小鼠肺腺癌亚系的生物学性质的比较[J].基础医学与临床,1993,13(2):36-39. 被引量：2
-
7朱国栋,刑俊平.前列腺活检后尿液中甲基化的GSTP1检测对诊断前列腺癌的意义[J].现代泌尿外科杂志,2004,9(2):118-118.
-
8程毅,魏贵亮,周宁,吴迎爽,谢震,祁贺,薄爱华,张晓立,邢立强.热休克蛋白70在乳腺癌和胃癌中的表达及其意义的研究[J].河北北方学院学报（医学版）,2005,22(5):23-24. 被引量：4
-
9陈鸿杰（综述）,杨宁刚（综述）,王民三（综述）.前列腺癌新瘤标在诊断中的研究进展[J].国际泌尿系统杂志,2007,27(6):806-808.
-
10李跃进,李登清,谭湘芳,方勇.血清T-PSA、F-PSA水平和F/T比值与前列腺癌病理分级的相关性[J].实用预防医学,2007,14(2):344-345. 被引量：2
